Evaluation and medical management of erectile dysfunction

被引:16
作者
Beckman, TJ
Abu-Lebdeh, HS
Mynderse, LA
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Coll Med, Dept Urol, Rochester, MN 55905 USA
关键词
D O I
10.4065/81.3.385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.
引用
收藏
页码:385 / 390
页数:6
相关论文
共 36 条
[1]  
American Association of Clinical Endocrinologists, 2002, ENDOCR PRACT, V8, P440
[2]   PHYSIOLOGY OF PENILE ERECTION [J].
ANDERSSON, KE ;
WAGNER, G .
PHYSIOLOGICAL REVIEWS, 1995, 75 (01) :191-236
[3]   Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease - A Randomized crossover trial [J].
Arruda-Olson, AM ;
Mahoney, DW ;
Nehra, A ;
Leckel, M ;
Pellikka, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (06) :719-725
[4]   Sexual function in men older than 50 years of age: Results from the health professionals follow-up study [J].
Bacon, CG ;
Mittleman, MA ;
Kawachi, I ;
Giovannucci, E ;
Glasser, DB ;
Rimm, EB .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) :161-168
[5]   CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS [J].
BEAVO, JA .
PHYSIOLOGICAL REVIEWS, 1995, 75 (04) :725-748
[6]   Sildenafil, a novel effective oral therapy for male erectile dysfunction [J].
Boolell, M ;
GepiAttee, S ;
Gingell, JC ;
Allen, MJ .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :257-261
[7]  
Cheitlin MD, 1999, J AM COLL CARDIOL, V34, P1850
[8]   Use of sildenafil (Viagra) in patients with cardiovascular disease [J].
Cheitlin, MD ;
Hutter, AM ;
Brindis, RG ;
Ganz, P ;
Kaul, S ;
Russell, RO ;
Zusman, RM ;
Forrester, JS ;
Douglas, PS ;
Faxon, DP ;
Fisher, JD ;
Gibbons, RJ ;
Halperin, JL ;
Hochman, JS ;
Kaul, S ;
Weintraub, WS ;
Winters, WL ;
Wolk, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :273-282
[9]   Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction [J].
Corbin, JD ;
Francis, SH ;
Webb, DJ .
UROLOGY, 2002, 60 (2B) :4-11
[10]   Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel [J].
DeBusk, R ;
Drory, Y ;
Goldstein, I ;
Jackson, G ;
Kaul, S ;
Kimmel, SE ;
Kostis, JB ;
Kloner, RA ;
Lakin, M ;
Meston, CM ;
Mittleman, M ;
Muller, JE ;
Padma-Nathan, H ;
Rosen, RC ;
Stein, RA ;
Zusman, R .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (02) :175-181